Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153302018> ?p ?o ?g. }
- W2153302018 endingPage "1222" @default.
- W2153302018 startingPage "1218" @default.
- W2153302018 abstract "Purpose To determine the efficacy of photodynamic therapy (PDT) in the treatment of choroidal metastasis. Design Retrospective, interventional case series. Participants Nine tumors in 8 eyes of 8 patients. Intervention Photodynamic therapy using verteporfin at a dose of 6 mg/m2 body surface area and 689 nm diode laser at an intensity of 600 mW/cm2 for 83 seconds (50 J/cm2). Main Outcome Measures Tumor control and best-corrected visual acuity. Results Nine choroidal metastases in 8 eyes were treated with 1 (8 tumors) or 2 (1 tumor) sessions of PDT. The mean tumor basal diameter was 7 mm (median, 7 mm [range, 2–13 mm]), and mean tumor thickness was 2.9 mm (median, 2.9 mm [range, 1.6–4 mm]). All 9 tumors were associated with shallow subretinal fluid. After PDT, complete control with resolution of subretinal fluid was achieved in 7 tumors (78%), with mean tumor thickness reduction of 39% (median, 43% [range, 6%–61%]). Two tumors failed to respond to PDT, both requiring plaque radiotherapy. Improvement or stabilization of vision was achieved in 7 eyes. Photodynamic therapy–related complications included intraretinal hemorrhage in 1 eye. Conclusions Photodynamic therapy can be an effective alternative for the treatment of choroidal metastasis. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article. To determine the efficacy of photodynamic therapy (PDT) in the treatment of choroidal metastasis. Retrospective, interventional case series. Nine tumors in 8 eyes of 8 patients. Photodynamic therapy using verteporfin at a dose of 6 mg/m2 body surface area and 689 nm diode laser at an intensity of 600 mW/cm2 for 83 seconds (50 J/cm2). Tumor control and best-corrected visual acuity. Nine choroidal metastases in 8 eyes were treated with 1 (8 tumors) or 2 (1 tumor) sessions of PDT. The mean tumor basal diameter was 7 mm (median, 7 mm [range, 2–13 mm]), and mean tumor thickness was 2.9 mm (median, 2.9 mm [range, 1.6–4 mm]). All 9 tumors were associated with shallow subretinal fluid. After PDT, complete control with resolution of subretinal fluid was achieved in 7 tumors (78%), with mean tumor thickness reduction of 39% (median, 43% [range, 6%–61%]). Two tumors failed to respond to PDT, both requiring plaque radiotherapy. Improvement or stabilization of vision was achieved in 7 eyes. Photodynamic therapy–related complications included intraretinal hemorrhage in 1 eye. Photodynamic therapy can be an effective alternative for the treatment of choroidal metastasis." @default.
- W2153302018 created "2016-06-24" @default.
- W2153302018 creator A5001760520 @default.
- W2153302018 creator A5051300937 @default.
- W2153302018 creator A5057488780 @default.
- W2153302018 creator A5066304115 @default.
- W2153302018 creator A5067553469 @default.
- W2153302018 date "2012-06-01" @default.
- W2153302018 modified "2023-09-23" @default.
- W2153302018 title "Photodynamic Therapy for Choroidal Metastasis in 8 Cases" @default.
- W2153302018 cites W1601975653 @default.
- W2153302018 cites W1959479860 @default.
- W2153302018 cites W1966288262 @default.
- W2153302018 cites W1969095582 @default.
- W2153302018 cites W1983792009 @default.
- W2153302018 cites W1986068858 @default.
- W2153302018 cites W1995357811 @default.
- W2153302018 cites W1997343362 @default.
- W2153302018 cites W1998372511 @default.
- W2153302018 cites W1999841737 @default.
- W2153302018 cites W2002288823 @default.
- W2153302018 cites W2002923053 @default.
- W2153302018 cites W2003404894 @default.
- W2153302018 cites W2003583934 @default.
- W2153302018 cites W2014536244 @default.
- W2153302018 cites W2015315582 @default.
- W2153302018 cites W2016423544 @default.
- W2153302018 cites W2019567173 @default.
- W2153302018 cites W2025634016 @default.
- W2153302018 cites W2053032874 @default.
- W2153302018 cites W2082507486 @default.
- W2153302018 cites W2083363345 @default.
- W2153302018 cites W2088847910 @default.
- W2153302018 cites W2123108676 @default.
- W2153302018 cites W2152133650 @default.
- W2153302018 cites W2163366742 @default.
- W2153302018 cites W2169259779 @default.
- W2153302018 cites W38123805 @default.
- W2153302018 cites W4211024586 @default.
- W2153302018 cites W4239557154 @default.
- W2153302018 doi "https://doi.org/10.1016/j.ophtha.2011.12.024" @default.
- W2153302018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22386261" @default.
- W2153302018 hasPublicationYear "2012" @default.
- W2153302018 type Work @default.
- W2153302018 sameAs 2153302018 @default.
- W2153302018 citedByCount "53" @default.
- W2153302018 countsByYear W21533020182012 @default.
- W2153302018 countsByYear W21533020182013 @default.
- W2153302018 countsByYear W21533020182014 @default.
- W2153302018 countsByYear W21533020182015 @default.
- W2153302018 countsByYear W21533020182016 @default.
- W2153302018 countsByYear W21533020182017 @default.
- W2153302018 countsByYear W21533020182018 @default.
- W2153302018 countsByYear W21533020182019 @default.
- W2153302018 countsByYear W21533020182020 @default.
- W2153302018 countsByYear W21533020182021 @default.
- W2153302018 countsByYear W21533020182022 @default.
- W2153302018 countsByYear W21533020182023 @default.
- W2153302018 crossrefType "journal-article" @default.
- W2153302018 hasAuthorship W2153302018A5001760520 @default.
- W2153302018 hasAuthorship W2153302018A5051300937 @default.
- W2153302018 hasAuthorship W2153302018A5057488780 @default.
- W2153302018 hasAuthorship W2153302018A5066304115 @default.
- W2153302018 hasAuthorship W2153302018A5067553469 @default.
- W2153302018 hasConcept C118487528 @default.
- W2153302018 hasConcept C120665830 @default.
- W2153302018 hasConcept C121332964 @default.
- W2153302018 hasConcept C121608353 @default.
- W2153302018 hasConcept C126322002 @default.
- W2153302018 hasConcept C126838900 @default.
- W2153302018 hasConcept C141071460 @default.
- W2153302018 hasConcept C167135981 @default.
- W2153302018 hasConcept C178790620 @default.
- W2153302018 hasConcept C185592680 @default.
- W2153302018 hasConcept C2776694393 @default.
- W2153302018 hasConcept C2777093970 @default.
- W2153302018 hasConcept C2778257484 @default.
- W2153302018 hasConcept C2779013556 @default.
- W2153302018 hasConcept C2781148688 @default.
- W2153302018 hasConcept C2781323092 @default.
- W2153302018 hasConcept C2781359195 @default.
- W2153302018 hasConcept C509974204 @default.
- W2153302018 hasConcept C71924100 @default.
- W2153302018 hasConceptScore W2153302018C118487528 @default.
- W2153302018 hasConceptScore W2153302018C120665830 @default.
- W2153302018 hasConceptScore W2153302018C121332964 @default.
- W2153302018 hasConceptScore W2153302018C121608353 @default.
- W2153302018 hasConceptScore W2153302018C126322002 @default.
- W2153302018 hasConceptScore W2153302018C126838900 @default.
- W2153302018 hasConceptScore W2153302018C141071460 @default.
- W2153302018 hasConceptScore W2153302018C167135981 @default.
- W2153302018 hasConceptScore W2153302018C178790620 @default.
- W2153302018 hasConceptScore W2153302018C185592680 @default.
- W2153302018 hasConceptScore W2153302018C2776694393 @default.
- W2153302018 hasConceptScore W2153302018C2777093970 @default.
- W2153302018 hasConceptScore W2153302018C2778257484 @default.
- W2153302018 hasConceptScore W2153302018C2779013556 @default.
- W2153302018 hasConceptScore W2153302018C2781148688 @default.